Studies on Human Factor VIII and its Antibodies Using Radiolabelling and Affinity Chromatography

Summary

An immuno-affinity chromatography method was used to isolate human factor VIII and its antibodies and the mechanism of the affinity system was investigated using iodine labelling.

Rabbit antibodies to human factor VIII were insolubilised onto CNBr — activated Sepharose 2B which was used for the preparation of affinity columns. Both VIII:C and VIIIR:Ag were adsorbed onto such columns from factor VIII preparations. The subsequent application of immunoglobulin preparations containing human antibodies to factor VIII resulted in the adsorption of these antibodies onto the columns. Adsorbed material was eluted from the affinity columns with 0.2 M glycine - HCl, pH 2.3.

When ¹²⁵I-labelled factor VIII and ¹³¹I-labelled human antibodies to factor VIII were used in this affinity system, the eluted material could be separated into three fractions by gel filtration on Bio-Gel A 1.5 m. Fraction 1 occurred at the void volume position, fraction 3 at a position corresponding to the elution position of IgG and fraction 2 at an intermediate position. ¹³¹I-labelled material was present in all three peaks. ¹²⁵I-labelled material was present mainly in peak 1, with a little in peak 2. The results support the view that VIIIR: Ag, which binds heterologous antibodies, is non-covalently linked to a smaller subunit, VIII.C, which binds homologous antibodies.

Keywords

Factor VIII - Radiolabelled factor VIII - Radiolabelled antibodies to factor VIII

• References

• 1 Owen WG, Wagner RH. Antihemophilic factor: separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 1972; 27: 502-515
• 2 Weiss HJ, Hoyer LW. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity. Science 1973; 182: 1149-1151
• 3 Rick ME, Hoyer LW. Immunologic studies of AHF (factor VIII), immunologic properties of AHF subunits produced by salt dissociation. Blood 1973; 42: 737-747
• 4 Cooper H, Wagner RH. The defect in hemophilic and von Willebrand’s disease plasmas studied by a recombination technique. J Clin Invest 1974; 54: 1093-1099
• 5 Rick ME, Hoyer LW. Molecular weight of human factor VIII procoagulant activity. Thromb Res 1975; 7: 909-916
• 6 Poon MC, Ratnoff O. Evidence that functional subunits of antihemophilic factor (factor VIII) are linked by non-covalent bonds. Blood 1976; 48: 87-94
• 7 Zimmerman TS, Edgington TS. Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med 1973; 138: 1015-1020
• 8 Peake IR, Bloom AL. The dissociation of factor VIII by reducing agents, high salt concentration and affinity chromatography. Thromb Haemostas 1976; 35: 191-201
• 9 Koutts J, Lavergne JM, Meyer D. Immunological evidence that human factor VIII is composed of two linked moieties. Br J Haematol 1977; 37: 415-428
• 10 Lane J, Ekert H, Vafiadis A. Affinity chromatography of human factor VIII using human and rabbit antibodies to factor VIII. Thromb Haemostas 1979; 42: 1306-1315
• 11 Hoyer LW. Immunologic studies of anti-hemophilic factor (AHF, factor VIII). III. Comparative binding properties of human and rabbit anti-AHF. Blood 1972; 39: 481-489
• 12 Lavergne JM, Meyer D, Reisner H. Characterization of human antifactor VIII antibodies purified by immune complex formation. Blood 1976; 48: 931-939
• 13 Allain JP, Frommel D. Antibodies to factor VIII. I. Variations in stability of antigen-antibody complexes in hemophilia A. Blood 1973; 42: 437-444
• 14 Lazarchick J, Hoyer LW. The properties of immune complexes formed by human antibodies to factor VIII. J Clin Invest 1977; 60: 1070-1079
• 15 Lavergne JM, Meyer D, Koutts J, Larrieu MJ. Isolation of human antibodies to factor VIII. Br J Haematol 1978; 40: 631-641
• 16 Rizza CR, Biggs R. The treatment of patients who have factor VIII antibodies. Br J Haematol 1973; 24: 65-82
• 17 Kavanagh ML, Wood CN, Davidson JF. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography. Thromb Haemostas 1981; 45: 60-64
• 18 Fine JM, Steinbuch M. A simple technique for the isolation of monoclonal IgG and IgA. Eur J Clin Biol Res 1970; 15: 1115-1121
• 19 Steinbuch M, Audran R. The isolation of IgG from mammalian sera with the aid of caprylic (octanoic) acid. Arch Biochem Biophys 1969; 134: 279-284
• 20 March S, Parikh I, Cuatrecasas P. A simplified method for the CNBr activation of agarose for affinity chromatography. Anal Biochem 1974; 60: 149-152
• 21 Hallaba E, Drouet J. ¹³¹I-labelling of human serum albumin by the iodinemonochloride and chloramine-T methods. Int J Appl Radiat Isot 1971; 22: 46-49
• 22 Caro RA, Ciscato VA, De GiacominiS M V, Quiroga S, Radicella R. Labelling of proteins with¹²⁵I and experimental determination of its specific activity. Int J Appl Radiat Isot 1975; 26: 527-532
• 23 Zimmerman TS, Ratnoff O, Powell A. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease. J Clin Invest 1971; 50: 244-254
• 24 Stites DP, Hershgold EJ, Perlman JD, Fudenberg HH. Factor VIII detection by hemagglutination inhibition: hemophilia and von Willebrand’s disease. Science 1971; 171: 196-197
• 25 Hoyer LW. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med 1972; 80: 822-833
• 26 Denson KW E. The detection of factor VIII-like antigen in haemophilic carriers and in patients with raised levels of biologically active factor VIII. Br J Haematol 1973; 24: 451-461
• 27 Peake IR, Bloom AL. Immunoradiometric assay of procoagulant factor VIII antigen in plasma and serum and its reduction in haemophilia. Lancet 1978; 01: 473-475